Highlights
ANI, New Delhi
Published by: Surendra Joshi
Updated Tue, 22 Feb 2022 12:22 PM IST
Summary
The central government has already allowed its limited use for adults. Based on the interim results of Phase II and III trials, its use has also been allowed for children in the age group of 12 to 18 years.
biological e corbevax for child
– Photo : amar ujala
hear the news
Expansion
The Central Drugs Laboratory (CDL) at Kasauli, Himachal has approved 6.5 crore doses of Corbivax, an anti-Covid-19 vaccine prepared by Biological E. This vaccine has met the criteria of safety, quality and effectiveness in laboratory tests.
Official sources gave this information on Tuesday. The central government has already allowed limited use of Corbivax for adults. Based on the interim results of its Phase II and III trials, its limited emergency use has also been allowed for children in the age group of 12 to 18 years. The central government has ordered the purchase of five crore vaccines.